Octapharma USA

Octapharma USA – Product Catalog (A–Z)

NUWIQ → Generic: simoctocog alfa (recombinant Factor VIII, human cell line) → Indication: Hemophilia A (prevention & treatment of bleeding episodes) → Dose: Injection vials 250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

NUWIQ RT → Generic: simoctocog alfa (room temperature–stable) → Indication: Hemophilia A → Dose: Injection vials same range (up to 3000 IU)

OCTAGAM 5% → Generic: immune globulin intravenous (human) → Indication: Primary immunodeficiency (PID), idiopathic thrombocytopenic purpura (ITP), chronic inflammatory demyelinating polyneuropathy (CIDP – some markets) → Dose: IV infusion, 5% solution (50 mg/mL), vials 1 g–10 g

OCTAGAM 10% → Generic: immune globulin intravenous (human) → Indication: Same as above (PID, ITP, CIDP) → Dose: IV infusion, 10% solution (100 mg/mL), vials 2 g–20 g

WILATE → Generic: human von Willebrand factor (vWF) + coagulation factor VIII complex → Indication: von Willebrand disease, Hemophilia A → Dose: Lyophilized powder for injection, vials 500 IU, 1000 IU, 2000 IU

FIBRYGA → Generic: human fibrinogen concentrate → Indication: Congenital fibrinogen deficiency, acquired fibrinogen deficiency (surgery, trauma, bleeding) → Dose: Vials 1 g, 2 g lyophilized powder for reconstitution

PENTAGLOBIN → Generic: immune globulin intravenous (IgM-enriched) → Indication: Severe bacterial infections, sepsis (adjunctive therapy, select use in U.S.) → Dose: IV infusion, 50 mg/mL solution

OCTAPLASLG → Generic: solvent/detergent treated human plasma (S/D plasma) → Indication: Coagulation factor deficiencies, liver disease, cardiac surgery, TTP (when plasma exchange needed) → Dose: Frozen plasma, 200 mL bags, thaw before use